We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Analyzing Method Enhances Stress Test Data

By HospiMedica staff writers
Posted on 13 Apr 2006
A new method for analyzing cardiac stress testing data can show whether patients are more than 10 times as likely to die of cardiovascular causes, including a fatal heart attack.

A new method of analyzing cardiac stress testing data has been developed by Cardiac Science (Bothwell, WA, USA) and researched in collaboration with Stanford University Medical Center (California, USA) and the Veterans Affairs Palo Alto Health Care System (California, USA). More...
This new method extracts significant prognostic information from cardiac stress test data. Patients in the test population with abnormal heart rate variability, when combined with an abnormal Duke Treadmill Score, were found to be more than 10 times as likely to experience cardiovascular death (CVD). However, when using the Duke Treadmill Score alone, the current "gold standard” for assessing cardiovascular risk, these patients were only identified as being three to four times more likely to experience CVD. The findings were announced at the American College of Cardiology's 55th Annual Scientific Session in Atlanta (Georgia, USA) in March 2006.

"These exciting results were developed through a substantial study population of nearly 2,000 patients with 70 deaths occurring from cardiovascular causes over the five-year follow-up,” said Dr. Victor Froelicher, professor of medicine at the Stanford University School of Medicine, and director of the [electrocardiogram] ECG and exercise laboratories at the Palo Alto VA Health Care System. "We are excited about the potential to extend the value of cardiac stress testing, already recognized as a gold standard in the identification of coronary artery disease, into important new diagnostic dimensions.”




Related Links:
Cardiac Science Corporation
Stanford University Medical Center
Veterans Affairs Palo Alto Health Care System

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.